PL2146209T3 - Neurodegeneratywne markery choroby Alzheimera - Google Patents
Neurodegeneratywne markery choroby AlzheimeraInfo
- Publication number
- PL2146209T3 PL2146209T3 PL09013088T PL09013088T PL2146209T3 PL 2146209 T3 PL2146209 T3 PL 2146209T3 PL 09013088 T PL09013088 T PL 09013088T PL 09013088 T PL09013088 T PL 09013088T PL 2146209 T3 PL2146209 T3 PL 2146209T3
- Authority
- PL
- Poland
- Prior art keywords
- disease
- alzheimer
- markers
- neurodegenerative
- values
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 4
- 230000000626 neurodegenerative effect Effects 0.000 title 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 239000007857 degradation product Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Eye Examination Apparatus (AREA)
- Medicines Containing Plant Substances (AREA)
- Mushroom Cultivation (AREA)
- Input From Keyboards Or The Like (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05007558 | 2005-04-06 | ||
| EP06723873A EP1866650B1 (de) | 2005-04-06 | 2006-03-30 | Neurodegenerative marker für depression. |
| EP09013088A EP2146209B1 (de) | 2005-04-06 | 2006-03-30 | Neurodegenerative Marker für Alzheimer-Krankheit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2146209T3 true PL2146209T3 (pl) | 2012-05-31 |
Family
ID=36293430
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09013088T PL2146209T3 (pl) | 2005-04-06 | 2006-03-30 | Neurodegeneratywne markery choroby Alzheimera |
| PL06723873T PL1866650T3 (pl) | 2005-04-06 | 2006-03-30 | Neurodegeneracyjne markery depresji |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06723873T PL1866650T3 (pl) | 2005-04-06 | 2006-03-30 | Neurodegeneracyjne markery depresji |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20080131921A1 (de) |
| EP (2) | EP1866650B1 (de) |
| JP (1) | JP4958893B2 (de) |
| AT (2) | ATE534038T1 (de) |
| CY (1) | CY1110116T1 (de) |
| DE (1) | DE602006014379D1 (de) |
| DK (2) | DK1866650T3 (de) |
| ES (2) | ES2346467T3 (de) |
| NO (2) | NO20075671L (de) |
| PL (2) | PL2146209T3 (de) |
| PT (2) | PT1866650E (de) |
| SI (1) | SI1866650T1 (de) |
| WO (1) | WO2006105907A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5856364B2 (ja) * | 2006-08-04 | 2016-02-09 | 味の素株式会社 | 抑うつ病の評価方法、抑うつ病評価装置、抑うつ病評価方法、抑うつ病評価システム、抑うつ病評価プログラム、記録媒体および端末装置 |
| AT9843U1 (de) | 2007-03-27 | 2008-04-15 | Kepplinger Berthold Dr | Messung von biologischen markern |
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| JP5410997B2 (ja) * | 2008-01-31 | 2014-02-05 | 則行 川村 | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
| WO2009100243A2 (en) * | 2008-02-05 | 2009-08-13 | University Of Miami | Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients |
| JPWO2011019072A1 (ja) | 2009-08-12 | 2013-01-17 | ヒューマン・メタボローム・テクノロジーズ株式会社 | うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体 |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| DK2778233T3 (en) | 2011-11-10 | 2017-03-20 | Human Metabolome Tech Inc | METHOD OF MEASURING ETHANOLAMINPHOSPHATE |
| EA201590024A1 (ru) | 2012-06-15 | 2015-05-29 | Гарри Стилли | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| WO2014068144A1 (en) | 2012-11-05 | 2014-05-08 | Ospedale San Raffaele S.R.L. | Biomarkers of multiple myeloma development and progression |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| EP2799878A1 (de) * | 2013-05-03 | 2014-11-05 | SALION GmbH | In vitro Verfahren zur Früherkennung von potenziellen Entzündungen, insbesondere im Zusammenhang mit der Abstoßung eines Transplantats |
| US20160003857A1 (en) * | 2014-07-02 | 2016-01-07 | Cecil Bennett | Methods and systems for detecting polypharmacy |
| EP4428251A3 (de) | 2014-09-11 | 2024-12-18 | Immunis.AI, Inc. | Verfahren zum nachweis von prostatakrebs |
| WO2017185085A1 (en) * | 2016-04-22 | 2017-10-26 | Board Of Regents Of The University Of Nebraska | Biomarkers for monitoring immune transformation |
| EP3413050A1 (de) * | 2017-06-08 | 2018-12-12 | SALION GmbH | In vitro verfahren zur erkennung neurodegenerativer erkrankungen |
| US11079329B2 (en) * | 2017-09-27 | 2021-08-03 | University of North Carolina Wilmington | Human waste water and human-derived pathogen scouting tool |
| US20210041460A1 (en) * | 2018-03-19 | 2021-02-11 | Fujifilm Wako Pure Chemical Corporation | Method for judging psychiatric disorder |
| WO2019182003A1 (ja) * | 2018-03-22 | 2019-09-26 | 株式会社日本医療機器技研 | 生体吸収性ステント |
| KR102159344B1 (ko) * | 2019-08-05 | 2020-09-23 | 한국과학기술연구원 | 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법 |
| WO2021106724A1 (ja) * | 2019-11-26 | 2021-06-03 | 京セラ株式会社 | ストレス計測システムおよびストレス計測方法 |
| WO2022075354A1 (en) * | 2020-10-06 | 2022-04-14 | Okinawa Institute Of Science And Technology School Corporation | A method for obtaining an index for the diagnosis of alzheimer's disease (ad) |
| WO2024253194A1 (ja) * | 2023-06-08 | 2024-12-12 | 東洋紡株式会社 | 脳機能レベルの層別化を支援するための方法、層別化装置、及び層別化プログラム |
| CN118566488B (zh) * | 2024-04-10 | 2026-02-27 | 合肥歆智医疗器械有限公司 | 抑郁症检测用试剂组合、制造方法、检测系统及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194217B1 (en) * | 1980-01-14 | 2001-02-27 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
| JP2000131318A (ja) * | 1998-10-22 | 2000-05-12 | Nikken Foods Co Ltd | 快・不快ストレス状態解析方法 |
| EP1050758A1 (de) * | 1999-05-03 | 2000-11-08 | Evotec BioSystems AG | Methoden zur Diagnostizierung oder zur Behandlung von neuropsychiatrischen Erkrankungen, die auf erhöhten Neurotrophin 3-Spiegel basiert sind |
| FR2827045B1 (fr) * | 2001-07-05 | 2007-08-10 | Univ Pasteur | Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments |
| JP2004198325A (ja) * | 2002-12-19 | 2004-07-15 | Oriental Yeast Co Ltd | ストレスの測定方法 |
-
2006
- 2006-03-30 DK DK06723873.3T patent/DK1866650T3/da active
- 2006-03-30 EP EP06723873A patent/EP1866650B1/de not_active Expired - Lifetime
- 2006-03-30 DE DE602006014379T patent/DE602006014379D1/de not_active Expired - Lifetime
- 2006-03-30 PT PT06723873T patent/PT1866650E/pt unknown
- 2006-03-30 AT AT09013088T patent/ATE534038T1/de active
- 2006-03-30 DK DK09013088.1T patent/DK2146209T3/da active
- 2006-03-30 WO PCT/EP2006/002907 patent/WO2006105907A1/en not_active Ceased
- 2006-03-30 JP JP2008504669A patent/JP4958893B2/ja not_active Expired - Fee Related
- 2006-03-30 AT AT06723873T patent/ATE468537T1/de active
- 2006-03-30 PL PL09013088T patent/PL2146209T3/pl unknown
- 2006-03-30 US US11/887,486 patent/US20080131921A1/en not_active Abandoned
- 2006-03-30 PT PT09013088T patent/PT2146209E/pt unknown
- 2006-03-30 PL PL06723873T patent/PL1866650T3/pl unknown
- 2006-03-30 ES ES06723873T patent/ES2346467T3/es not_active Expired - Lifetime
- 2006-03-30 SI SI200630658T patent/SI1866650T1/sl unknown
- 2006-03-30 ES ES09013088T patent/ES2377704T3/es not_active Expired - Lifetime
- 2006-03-30 EP EP09013088A patent/EP2146209B1/de not_active Expired - Lifetime
-
2007
- 2007-11-06 NO NO20075671A patent/NO20075671L/no not_active Application Discontinuation
-
2010
- 2010-06-11 CY CY20101100535T patent/CY1110116T1/el unknown
-
2012
- 2012-02-21 US US13/401,397 patent/US20120196300A1/en not_active Abandoned
- 2012-04-18 NO NO20120452A patent/NO20120452L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4958893B2 (ja) | 2012-06-20 |
| PT1866650E (pt) | 2010-06-01 |
| SI1866650T1 (sl) | 2010-12-31 |
| NO20075671L (no) | 2007-11-06 |
| EP2146209B1 (de) | 2011-11-16 |
| EP1866650B1 (de) | 2010-05-19 |
| ES2346467T3 (es) | 2010-10-15 |
| WO2006105907A1 (en) | 2006-10-12 |
| ATE468537T1 (de) | 2010-06-15 |
| DK2146209T3 (da) | 2012-02-13 |
| PT2146209E (pt) | 2011-12-30 |
| ATE534038T1 (de) | 2011-12-15 |
| US20120196300A1 (en) | 2012-08-02 |
| HK1137219A1 (en) | 2010-07-23 |
| DE602006014379D1 (de) | 2010-07-01 |
| NO20120452L (no) | 2007-11-06 |
| PL1866650T3 (pl) | 2011-04-29 |
| CY1110116T1 (el) | 2015-01-14 |
| EP1866650A1 (de) | 2007-12-19 |
| DK1866650T3 (da) | 2010-09-06 |
| US20080131921A1 (en) | 2008-06-05 |
| EP2146209A1 (de) | 2010-01-20 |
| JP2008537111A (ja) | 2008-09-11 |
| ES2377704T3 (es) | 2012-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1866650T1 (sl) | Nevrodegenerativni markerji za depresijo | |
| WO2005047484A3 (en) | Biomarkers for alzheimer's disease | |
| PL1945622T3 (pl) | Izotopowo znaczone związki benzofuranu jako środki obrazujące białka amyloidogenne | |
| IL188165A0 (en) | Method for the diagnosis of alzheimer's disease | |
| GB0512401D0 (en) | Method | |
| IL211540A (en) | Optical method for detecting Alzheimer's disease | |
| AU2010202926B2 (en) | Markers and methods relating to the assessment of Alzheimer's disease | |
| EP1872705A4 (de) | Endoskopförmige nachweisvorrichtung | |
| EP1943835A4 (de) | Verfahren zum angeben von diensttypen in einer dienstanleitung | |
| ZA200810528B (en) | Procedure and methods for detecting Alzheimer's disease | |
| ZA200800975B (en) | Oral, quickly disintegrating film, which cannot be spat out, for an antiemetic or antimigraine agent | |
| WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
| WO2007028161A3 (en) | Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states | |
| FR2874675B1 (fr) | Frein pour roue avec capteur d'usure | |
| AU2374302A (en) | Means for detecting pathological transformation of the app protein and their uses | |
| WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
| EP1855525A4 (de) | Zebrafisch-modelle zur behandlung von alzheimer | |
| FR2890446B1 (fr) | Methode de detection d'interaction intracellulaire entre bio-molecules | |
| WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
| ATE414904T1 (de) | Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo | |
| WO2005116659A3 (en) | Compositions and methods relating to alzheimer’s disease | |
| GB0622194D0 (en) | Method for diagnosing or detecting alzheimer's disease | |
| FR2852096B1 (fr) | Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque. | |
| EP1907838A4 (de) | Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer | |
| Zhu | Measuring Human Capital in Canada by Gender |